Why Anthem is a 2nd or 3rd choice for investors

While Anthem has posted impressive earnings in the first two quarters of 2019 and raised its guidance twice, investors are questioning Anthem’s efficiency as its medical cost ratio grows, according to Seeking Alpha.

Advertisement

Anthem’s medical cost ratio, or the amount it pays toward medical claims versus overhead costs, is the highest in the health insurance industry, according to the report. At a recent presentation at the Wells Fargo’s Healthcare Conference, Anthem traded lower after quoting its medical cost ratio outlook at 86.5 percent, up from 84.2 percent in 2018.

Growing medical cost ratios may signal healthcare companies are facing an inevitable trend of increasing medical costs. “With the industry trending lower, healthcare stocks look like an opportunity but Anthem’s cost struggles make it second or third best,” according to Seeking Alpha. 

Read more here.

More articles on payers:
General Motors cuts health plan for 50,000 striking employees
Massachusetts hospital president: BCBS putting profits over patients
UnitedHealth confirms $3.2B Equian deal

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Capital

Advertisement

Comments are closed.